Denali Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $204k | 9.9k | 20.63 |
| 2023-06-30 | $296k | 10k | 29.51 |
| 2023-03-31 | $263k | 11k | 23.04 |
| 2022-12-31 | $276k | 9.9k | 27.81 |
| 2021-12-31 | $220k | 4.9k | 44.66 |
| 2021-09-30 | $311k | 6.2k | 50.40 |
| 2021-06-30 | $501k | 6.4k | 78.42 |
| 2021-03-31 | $427k | 7.5k | 57.05 |
| 2020-12-31 | $631k | 7.5k | 83.78 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates